Tonix Pharmaceuticals Holding Corp. (TNXP) › Total AssetsTonix Pharmaceuticals Holding Corp. (TNXP) — Total AssetsAnnual figures by fiscal year, from SEC filings.2010: $184.0K2011: $425.4K2012: $2.12M2013: $8.74M2014: $39.54M2015: $47.02M2016: $27.51M2017: $26.75M2018: $26.32M2019: $14.56M2020: $98.18M2021: $240.90M2022: $225.69M2023: $154.46M2024: $162.89M2025: $277.17M$277.17M2010Total Assets (USD)2025Fiscal YearTotal AssetsChange YoY2025$277.17M+70.2%2024$162.89M+5.5%2023$154.46M-31.6%2022$225.69M-6.3%2021$240.90M+145.4%2020$98.18M+574.4%2019$14.56M-44.7%2018$26.32M-1.6%2017$26.75M-2.7%2016$27.51M-41.5%2015$47.02M+18.9%2014$39.54M+352.6%2013$8.74M+312.7%2012$2.12M+397.6%2011$425.4K+131.2%2010$184.0K—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share